![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Allergy Therapeutics hails progression of peanut allergy vaccine (Proactive Investors) View |
![]() |
Allergy Therapeutics' hail successful primary outcome of peanut allergy treatment (Proactive Investors) View |
![]() |
Allergy Therapeutics says US preparations are underway which include two pivotal trials (Proactive Investors) View |
![]() |
Allergy Therapeutics preparing the ground for big opportunities in the US (Proactive Investors) View |
![]() |
AR-101 and Viaskin Peanut: What's Next in Research (HCPLive) View |
![]() |
Allergy Therapeutics on track for phase III grass pollen trial in 2019 (Proactive Investors) View |
![]() |
Allergy Therapeutics outperforming the market (Proactive Investors) View |
![]() |
Allergy Therapeutics plc - Financial, Strategy u0026 operations update (Five Minute Pitch TV) View |
![]() |
Ergomed Plc adds to co-development pipeline with Allergy Therapeutics deal (Proactive Investors) View |
![]() |
Allergy Therapeutics boss says the firm is outperforming its competitors (Proactive Investors) View |